Literature DB >> 1466315

Epidemiology of triglycerides: a view from Framingham.

W P Castelli1.   

Abstract

New analyses from the Framingham Heart Study are presented showing that men and women who have high triglyceride levels (> 1.7 mmol/liter) and a low high-density lipoprotein (HDL) level (< 1.03 mmol/liter) run a significantly higher rate of coronary artery disease and can be identified, and that this risk group (high triglyceride-low HDL) is, independently of the major risk factors (including low HDL), related to occurrence of coronary artery disease. Further, this trait appears to be common in our society, producing twice as many cases of coronary artery disease during the 14 years of the Framingham study as the next highest disease-producing lipid abnormality. This trait of high triglyceride-low HDL is associated in the medical literature with increased insulin resistance, higher blood sugars (within the normal range), higher uric acid levels, hypertension, and centrally mediated obesity. Because total cholesterol in people with these traits may be less than or just slightly greater than 5.2 mmol/liter, they are missed or neglected by most cholesterol screening programs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1466315     DOI: 10.1016/0002-9149(92)91083-g

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  36 in total

Review 1.  Impact of dyslipidaemia. Lessons from clinical trials.

Authors:  W V Brown
Journal:  Pharmacoeconomics       Date:  1998       Impact factor: 4.981

Review 2.  Obesity and lipids.

Authors:  Wendy M Miller; Katherine E Nori-Janosz; Martin Lillystone; Jose Yanez; Peter A McCullough
Journal:  Curr Cardiol Rep       Date:  2005-11       Impact factor: 2.931

Review 3.  Management of lipid disorders in the elderly.

Authors:  D A Playford; G F Watts
Journal:  Drugs Aging       Date:  1997-06       Impact factor: 3.923

4.  Low-dose pravastatin and age-related differences in risk factors for cardiovascular disease in hypercholesterolaemic Japanese: analysis of the management of elevated cholesterol in the primary prevention group of adult Japanese (MEGA study).

Authors:  Noriaki Nakaya; Kyoichi Mizuno; Yasuo Ohashi; Tamio Teramoto; Shinji Yokoyama; Katsumi Hirahara; Masahiro Mizutani; Haruo Nakamura
Journal:  Drugs Aging       Date:  2011-09-01       Impact factor: 3.923

5.  Prediction of the population at risk for atherothrombotic disease.

Authors:  William E Feeman
Journal:  Exp Clin Cardiol       Date:  2004

Review 6.  Clinical relevance of reducing triglycerides. Implications for ischaemic heart disease treatment.

Authors:  A N Nafziger
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

Review 7.  The role of hypertriglyceridemia in atherosclerosis.

Authors:  Ngoc-Anh Le; Mary F Walter
Journal:  Curr Atheroscler Rep       Date:  2007-08       Impact factor: 5.113

8.  Prevention of Cardiovascular Disease in Women.

Authors:  Omer L. Shedd; Marian C. Limacher
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-08

9.  Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders.

Authors:  David J Heal; Jane Gosden; Sharon L Smith
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

Review 10.  Fenofibric acid: a new fibrate approved for use in combination with statin for the treatment of mixed dyslipidemia.

Authors:  Peter Alagona
Journal:  Vasc Health Risk Manag       Date:  2010-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.